"Smart tattoo" glucose biosensors and effect of coencapsulated anti-inflammatory agents

Journal of Diabetes Science and Technology

Volumn 5, Issue 1, 2011, Pages 76-85

  Srivastava, Rohit ^a   Jayant, Rahul Dev ^a   Chaudhary, Ayesha ^a   McShane, Michael J ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b Texas A M University   (United States)

Author keywords

Alginate; Anti inflammatory drugs; Controlled release; Glucose sensing; Layer by layer self assembly

Indexed keywords

ACETYLSALICYLIC ACID; ALGINIC ACID; ANTIINFLAMMATORY AGENT; CALCIUM ALGINATE; DEXAMETHASONE; DICLOFENAC; FLAVINE ADENINE NUCLEOTIDE; FLUORESCEIN ISOTHIOCYANATE; GLUCOSE OXIDASE; MICROSPHERE; POLYELECTROLYTE; DIAGNOSTIC AGENT; FLUORESCENT DYE; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLOOD GLUCOSE MONITORING; BODY FLUID; COATED PARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; DRUG FORMULATION; DRUG RELEASE; ENZYME ACTIVITY; FIBROBLAST; GLUCOSE SENSOR; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; RAT; SUBCUTANEOUS TISSUE; ANIMAL; ARTIFICIAL INTELLIGENCE; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; EVALUATION; GENETIC PROCEDURES; GLUCOSE BLOOD LEVEL; METHODOLOGY; SPRAGUE DAWLEY RAT;

ALGINATES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTIFICIAL INTELLIGENCE; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; DEXAMETHASONE; DICLOFENAC; DRUG COMBINATIONS; DRUG COMPOUNDING; FLUORESCENT DYES; GLUCOSE OXIDASE; GLUCURONIC ACID; HEXURONIC ACIDS; MICROSPHERES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79957987235     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500111     Document Type: Article

References (34)

1. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol. 2009;3(5):1031-8.
2. Valdes TI, Moussy F. In vitro and in vivo degradation of glucose oxidase enzyme used for an implantable glucose biosensor. Diabetes Technol Ther. 2000;2(3):367-76.
3. Pickup J, Rolinski O, Birch D. In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring. BMJ. 1999;319(7220):1289.
4. Pickup JC, Hussain F, Evans ND, Sachedina N. In vivo glucose monitoring: the clinical reality and the promise. Biosens Bioelectron. 2005;20(10):1897-902.
5. Gerritsen M, Jansen JA, Lutterman JA. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med. 1999;54(4):167-79.
6. Wickramasinghe Y, Yang Y, Spencer SA. Current problems and potential techniques in in vivo glucose monitoring. J Fluoresc. 2004;14(5):513-20.
7. Pickup JC, Hussain F, Evans ND, Rolinski OJ, Birch DJ. Fluorescence-based glucose sensors. Biosens Bioelectron. 2005;20(12):2555-65.
8. Hughes MD. The business of self-monitoring of blood glucose: a market profile. J Diabetes Sci Technol. 2009;3(5):1219-23.
9. McShane MJ. Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes Technol Ther. 2002;4(4):533-8.
10. Brown JQ, McShane MJ. Modeling of spherical fluorescent glucose microsensor systems: design of enzymatic smart tattoos. Biosens Bioelectron. 2006;21(9):1760-9.
11. Brown JQ, Srivastava R, Zhu H, McShane MJ. Enzymatic fluorescent microsphere glucose sensors: evaluation of response under dynamic conditions. Diabetes Technol Ther. 2006;8(3):288-95.
12. Chinnayelka S, McShane MJ. Microcapsule biosensors using competitive binding resonance energy transfer assays based on apoenzymes. Anal Chem. 2005;77(17):5501-11.
13. Stein EW, Grant PS, Zhu H, McShane MJ. Microscale enzymatic optical biosensors using mass transport limiting nanofilms. 1. Fabrication and characterization using glucose as a model analyte. Anal Chem. 2007;79(4):1339-48.
14. Freeland AC, Bonnecaze RT. Inference of blood glucose concentrations from subcutaneous glucose concentrations: applications to glucose biosensors. Ann Biomed Eng. 1999;27(4):525-37.
15. Thennadil SN, Rennert JL, Wenzel BJ, Hazen KH, Ruchti TL, Block MB. Comparison of glucose concentration in interstitial fluid, and capillary and venous blood during rapid changes in blood glucose levels. Diabetes Technol Ther. 2001;3(3):357-65.
16. Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabet Med. 2003;20(3):238-41.
17. McShane MJ, Rastegar S, Pishko M, Coté GL. Monte Carlo modeling for implantable fluorescent analyte sensors. IEEE Trans Biomed Eng. 2000;47(5):624-32.
18. Long R, McShane M. Optical instrument design for interrogation of dermally-implanted luminescent microparticle sensors. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5656-9.
19. Onuki Y, Bhardwaj U, Papadimitrakopoulos F, Burgess DJ. A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response. J Diabetes Sci Technol. 2008;2(6):1003-15.
20. Buckingham B, Caswell K, Wilson DM. Real-time continuous glucose monitoring. Curr Opin Endocrinol Diabetes Obes. 2007;14(4):288-95.
21. Wisniewski N, Reichert M. Methods for reducing biosensor membrane biofouling. Colloids Surf B Biointerfaces. 2000;18(3-4):197-219.
22. Norton LW, Tegnell E, Toporek SS, Reichert WM. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Biomaterials. 2005;26(16):3285-97.
23. Bhardwaj U, Sura R, Papadimitrakopoulos F, Burgess DJ. Controlling acute inflammation with fast releasing dexamethasone- PLGA microsphere/PVA hydrogel composites for implantable devices. J Diabetes Sci Techonol. 2007;1(1):8-17.
24. Galeska I, Kim TK, Patil SD, Bhardwaj U, Chatttopadhyay D, Papadimitrakopoulos F, Burgess DJ. Controlled release of dexamethasone from PLGA microspheres embedded within polyacidcontaining PVA hydrogels. AAPS J. 2005;7(1):E231-40.
25. Zolnik BS, Burgess DJ. Evaluation of in vivo - in vitro release of dexamethasone from PLGA microspheres. J Control Release. 2008;127(2):137-45.
26. Decher G, Lehr B, Lowack K, Lvov Y, Schmitt J. New nanocomposite films for biosensors: layer-by-layer adsorbed films of poly-electrolytes, proteins or DNA. Biosens Bioelectron. 1994;9(9-10):677-84.
27. Decher G, Lvov Y, Schmitt J. Proof of multilayer structural organization in self-assembled polycation- polyanion molecular films. Thin Solid Films. 1994;244(1-2):772-77.
28. Swoboda BE. The relationship between molecular conformation and the binding of flavin-adenine dinucleotide in glucose oxidase. Biochim Biophys Acta. 1969;175(2):365-79.
29. Chaudhary A, Srivastava R. Glucose sensing using competitive binding assay co-encapsulated in uniform sized alginate microspheres. Sens Lett. 2008;6(2):253-60.
30. Chaudhary A, Raina M, Harma H, Hanninen P, McShane MJ, Srivastava R. Evaluation of glucose sensitive affinity binding assay entrapped in fluorescent dissolved-core alginate microspheres. Biotechnol Bioeng. 2009;104(6):1075-85.
31. Chinnayelka S, McShane MJ. Resonance energy transfer nanobiosensors based on affinity binding between Apo-enzyme and its substrate. Biomacromolecules. 2004;5(5):1657-61.
32. Doherty GM, Humphreys HM. Fluid and electrolyte management. In: Doherty GM, Way LW, eds. Current surgical diagnosis and treatment. 12th ed. New York: McGraw-Hill; 2006, 127-39.
33. Jayant RD, Srivastava R. Dexamethasone release from uniform sized nanoengineered alginate microspheres. J Biomed Nanotechnol. 2007;3(3):1-9.
34. Jayant RD, McShane MJ, Srivastava R. Polyelectrolyte-coated alginate microspheres as drug delivery carriers for dexamethasone release. Drug Deliv. 2009;16(6):331-40.